Sy. Linshiau et Ks. Hsu, MODIFICATION OF 2,2',2''-TRIPYRIDINE-INDUCED TREMOR IN MICE BY SEROTONERGIC AGONISTS AND ANTAGONISTS AND BENZODIAZEPINES, Pharmacology, biochemistry and behavior, 48(3), 1994, pp. 665-670
The administration of 2,2 ',2 ''-tripyridine produced generalized trem
or, myoclonus, and hindlimb abduction, similar to the ''5-hydroxytrypt
amine (5-HT) syndrome,'' in mice. Pretreatment with mianserin, cyprohe
ptadine, methysergide, or metergoline ameliorated, whereas 5-hydroxytr
yptophan (5-HTP), 5-methoxy-N,N-dimethyltryptamine (5-MeODMT), or 8-hy
droxy-2-[di-n-propylamino]tetraline hydrobromide (8-OH-DPAT) augmented
the 2,2 ',2 ''-tripyridine-induced tremor. Furthermore, diazepam and
flunitrazepam exhibited a dose-dependent protection against 2,2 ',2 ''
-tripyridine-induced tremor in mice, but pentobarbital only had a sli
ghtly protective effect. The inhibitory effects of diazepam and flunit
razepam on the 2,2 ',2 ''-tripyridine-induced tremor were potentiated
in mice pretreated with-p-chlorophenylalanine (PCPA). These observatio
ns suggest a serotonin-mediated action of 2,2 ',2 ''-tripyridine in it
s tremor action and that the benzodiazepine agonist attenuation of the
2,2 ',2 ''-tripyridine-induced tremor is probably mediated through th
e GABAergic inhibition of serotonergic neurons.